The trial was paused in compliance with regulatory standards after an 'unexplained' illness in one of its participants, the company said.
Pfizer and Moderna also have vaccine candidate trials that went into phase 3 in July, both of which require two doses about a month apart. The Johnson & Johnson vaccine candidate is instead administered in one dose, avoiding the complicated coordination to require people to return in time for the second dose.
Johnson & Johnson announced last week that the European Commission had approved an advance purchase agreement from its parent company, Janssen Pharmaceutical Companies, for 200 million doses of the vaccine for E.U. member states following approval. The company also said it was looking to allocate up to 500 million vaccine doses to international efforts for low-income nations.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick SubjectThe company says an independent committee is reviewing the subject’s illness, and it will review the medical information before deciding whether to restart the studies
Read more »
Johnson & Johnson pauses Covid-19 vaccine trial after 'unexplained illness'Johnson&Johnson said its Janssen arm had paused its coronavirus vaccine trial after an 'unexplained illness' in one of the volunteers testing its experimental Covid-19 shot.
Read more »
Johnson & Johnson pauses clinical trials for a Covid-19 vaccine over participant's illnessJohnson & Johnson has paused its clinical trials for a Covid-19 vaccine candidate after a participant fell ill, just weeks after it announced that trials were in their final stage.
Read more »
Johnson & Johnson Halt All Covid-19 Vaccine Trials Over ‘Unexplained Illness’The pause includes late-stage stage trials for the group’s single dose Covid-19 vaccine.
Read more »